Primary Navigation for the CDC Website
CDC en Español
2005 Assisted Reproductive Technology (ART) Report: Section 4—ART Cycles Using Donor Eggs


Are older women undergoing ART more likely to use donor eggs or embryos?

As shown in Figures 1416, eggs produced by women in older age groups form embryos that are less likely to implant and more likely to result in miscarriage if they do implant. As a result, ART using donor eggs is much more common among older women than among younger women. Donor eggs or embryos were used in approximately 12% of all ART cycles carried out in 2005 (16,161 cycles). Figure 44 shows the percentage of ART cycles using donor eggs in 2005 according to the woman’s age. Few women younger than age 39 used donor eggs; however, the percentage of cycles carried out with donor eggs increased sharply starting at age 39. Among women older than age 47, for example, about 90% of all ART cycles used donor eggs.

Figure 44:Percentage of ART Cycles Using Donor Eggs, by ART Patient’s Age, 2005.

 

Figure 44: Percentage of ART Cycles Using Donor Eggs, by ART Patient’s Age, 2005.


Do success rates differ by age for women who used ART with donor eggs compared with women who used ART with their own eggs?

Figure 45 compares percentages of transfers resulting in live births for ART cycles using fresh embryos from donor eggs with those for ART cycles using a woman’s own eggs, among women of different ages. The likelihood of a fertilized egg implanting is related to the age of the woman who produced the egg. Egg donors are typically in their 20s or early 30s. Thus, the percentage of transfers resulting in live births for cycles using embryos from donor eggs varies only slightly across all age groups. The average percentage of transfers resulting in live births for cycles using embryos from donor eggs is 52%. In contrast, the percentage of transfers resulting in live births for cycles using embryos from women’s own eggs declines steadily as women get older.

Figure 45: Percentages of Transfers That Resulted in Live Births for ART Cycles Using Fresh Embryos from Own and Donor Eggs, by ART Patient’s Age, 2005.

 

Figure 45: Percentages of Transfers That Resulted in Live Births for ART Cycles Using Fresh Embryos from Own and Donor Eggs, by ART Patient’s Age, 2005.

 


How successful is ART when donor eggs are used?

Figure 46 shows percentages of transfers resulting in live births and singleton live births for ART cycles using fresh embryos from donor eggs among women of different ages. For all ages, the percentage of transfers resulting in singleton live births (average 31%) was lower than the percentage of transfers resulting in live births (average 52%). Singleton live births are an important measure of success because they have a much lower risk than multiple-infant births for adverse infant health outcomes, including prematurity, low birth weight, disability, and death.

Figure 46: Percentages of Transfers That Resulted in Live Births and Singleton Live Births for ART Cycles Using Fresh Embryos from Donor Eggs, by ART Patient’s Age, 2005.

 

Figure 46: Percentages of Transfers That Resulted in Live Births and Singleton Live Births for ART Cycles Using Fresh Embryos from Donor Eggs, by ART Patient’s Age, 2005.

 

 

 


What is the risk of having a multiple-fetus pregnancy or multiple-infant live birth from an ART cycle using fresh donor eggs?

Multiple-infant births are associated with greater problems for both mothers and infants, including higher rates of caesarean section, prematurity, low birth weight, and infant disability or death.

Part A of Figure 47 shows that among the 5,877 pregnancies that resulted from ART cycles using fresh embryos from donor eggs, about 53% were singleton pregnancies, about 38% were twins, and nearly 5% were triplets or more. About 5% of pregnancies ended in miscarriage before the number of fetuses could be accurately determined. Therefore, the percentage of pregnancies with more than one fetus might have been higher than what was reported (about 42%).

In 2005, 5,043 pregnancies from ART cycles that used fresh embryos from donor eggs resulted in live births. Part B of Figure 47 shows that 41% of these live births produced more than one infant (about 39% twins and about 2% triplets or more). This compares with a multiple-infant birth rate of slightly more than 3% in the general population.

Although the total rates for multiples were similar for pregnancies and live births, there were more triplet-or-more pregnancies than births. Triple-or-more pregnancies may be reduced to twins or singletons by the time of birth. This can happen naturally (e.g., fetal death), or a woman and her doctor may decide to reduce the number of fetuses using a procedure called multifetal pregnancy reduction. CDC does not collect information on multifetal pregnancy reductions.

Figure 47: Risks of Having Multiple-Fetus Pregnancy and Multiple-Infant Live Birth from ART Cycles Using Fresh Embryos from Donor Eggs, 2005.


Figure 47: Risks of Having Multiple-Fetus Pregnancy and Multiple-Infant Live Birth from ART Cycles Using Fresh Embryos from Donor Eggs, 2005.

 


How do success rates differ between women who use frozen donor embryos and those who use fresh donor embryos?

Figure 48 shows that the success rates resulting from the transfer of frozen donor embryos were substantially lower than the success rates resulting from the transfer of fresh donor embryos. This is similar to the findings for frozen nondonor embryos (see Figure 42). The average number of embryos transferred was similar for cycles using frozen donor embryos and those using fresh donor embryos. (See the national summary table for information on the average number of embryos transferred for these cycles.)

Figure 48: Success Rates for ART Cycles Using Frozen Donor and Fresh Donor Embryos, 2005.

 

Figure 48: Success Rates for ART Cycles Using Frozen Donor and Fresh Donor Embryos, 2005.

 

 

 

 


Section 1 | Section 2 | Section 3 | Section 4 | Section 5

Selected Resources

Previous ART Reports

Implementation of the Fertility Clinic Success Rate and Certification Act of 1992

Assisted Reproductive Technology: Embryo Laboratory

Page last reviewed: 12/12/07
Page last modified: 12/12/07
Content source: Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion

rectangle border
ART label image
bulletbullet Find a Clinic
bulletbullet National Summary Table
bulletbullet Download Report

bullet 2005 Report Home
bullet Acknowledgements
bullet Preface
bullet Commonly Asked Questions
bullet Introduction to the National Report
bullet Overview
bullet Fresh Nondonor Eggs or Embryos
bullet Frozen Nondonor Embryos
bullet Donor Eggs
bullet Trends, 1996–2005
bullet Introduction to Fertility Clinic Tables
bullet Sample Clinic Table
bullet How to Read a Fertility Clinic Table
bullet Confidence Intervals and Validation Findings
bullet Glossary of Terms
bullet Reporting Clinics
bullet Non-Reporting Clinics
bullet National Consumer Organizations
rectangle border

Reproductive Health related resources
bullet Reproductive Health Home
bullet Data and Statistics
bullet Publications and Products
bullet

Glossary

bullet Related Links

bullet Adolescent Reproductive Health
bullet Assisted Reproductive Technology
bullet Global Reproductive Health
bullet Maternal and Infant Health Research
bullet Refugee Reproductive Health
bullet Sudden Infant Death Syndrome
bullet Unintended Pregnancy
bullet Women's Reproductive Health

bullet Division of Reproductive Health

Contact Info
CDC/DRH
4770 Buford Hwy, NE
MS K-20
Atlanta, GA 30341-3717

Phone number
770-488-5200

bullet Contact Us

divider
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
Safer, Healthier People

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435
USAGov LogoDHHS Department of Health
and Human Services